Express News | Enanta Pharmaceuticals Inc : Evercore ISI Cuts Target Price to $30 From $35
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) shareholders are probably feeling a little disappointed, since its shares fell 8.3% to US$12.76 in the week after its latest quarterly results. Revenue
Enanta Pharmaceuticals | 10-Q: Quarterly report
Hold Rating on Enanta Pharmaceuticals Amidst Clinical Trials Uncertainty and Financial Outlook
Enanta Pharmaceuticals Is Maintained at Market Outperform by JMP Securities
Enanta Pharmaceuticals Is Maintained at Market Outperform by JMP Securities
Buy Rating Affirmed for Enanta Pharmaceuticals Amidst Promising RSV Developments and Clinical Trial Execution
Express News | JMP Securities Maintains Market Outperform on Enanta Pharma, Lowers Price Target to $22
Enanta Pharma Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/07/2024 67.81% JMP Securities $23 → $22 Maintains Market Outperform 02/08/2024 -16.09% JP Morgan $12 →
Express News | Enanta Pharmaceuticals Inc : H.c. Wainwright Cuts Target Price to $27 From $28
NanoViricides, TC BioPharm, Holdco Nuvo Among Healthcare Movers
Express News | Enanta Pharmaceuticals Inc : Oppenheimer Cuts Target Price to $16 From $17
Earnings Call Summary | Enanta Pharmaceuticals(ENTA.US) Q2 2024 Earnings Conference
The following is a summary of the Enanta Pharmaceuticals, Inc. (ENTA) Q2 2024 Earnings Call Transcript:Financial Performance:Enanta reported total Q2 revenue of $17.1 million from royalty revenue on A
Analysts' Opinions Are Mixed on These Healthcare Stocks: Enanta Pharmaceuticals (ENTA), OrthoPediatrics (KIDS) and Avanos Medical (AVNS)
Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference
PDF Version WATERTOWN, Mass.--(BUSINESS WIRE)--May 7, 2024-- Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology
Express News | Enanta Pharmaceuticals Inc : Leerink Partners Cuts Target Price to $12 From $13
Express News | Enanta Pharmaceuticals Inc: Qtrly Shr Loss $1.47
Earnings Flash (ENTA) ENANTA PHARMACEUTICALS Posts Q2 Revenue $17.1M, Vs. Street Est of $16.2M
04:04 PM EDT, 05/06/2024 (MT Newswires) -- Earnings Flash (ENTA) ENANTA PHARMACEUTICALS Posts Q2 Revenue $17.1M, vs. Street Est of $16.2M
Express News | Enanta Pharmaceuticals Q2 Revenue USD 17.054 Million Vs. Ibes Estimate USD 16.5 Million
Express News | Enanta Pharmaceuticals Q2 Operating Income USD -32.766 Million
Express News | Enanta Pharmaceuticals Q2 Operating Expenses USD 49.82 Million